BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33368325)

  • 1. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
    Leiva MC; Garre E; Gustafsson A; Svanström A; Bogestål Y; Håkansson J; Ståhlberg A; Landberg G
    J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
    Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
    J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
    Svanström A; Rosendahl J; Salerno S; Leiva MC; Gregersson P; Berglin M; Bogestål Y; Lausmaa J; Oko A; Chinga-Carrasco G; Petronis S; Standoft S; Ståhlberg A; Håkansson J; Landberg G
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34030145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
    Persson E; Gregersson P; Gustafsson A; Fitzpatrick P; Rhost S; Ståhlberg A; Landberg G
    Cell Commun Signal; 2021 Jun; 19(1):66. PubMed ID: 34090457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.
    Sharma B; Varney ML; Saxena S; Wu L; Singh RK
    Cancer Lett; 2016 Mar; 372(2):192-200. PubMed ID: 26797460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional tissue culture model of human breast cancer for the evaluation of multidrug resistance.
    Ding Y; Liu W; Yu W; Lu S; Liu M; Kaplan DL; Wang X
    J Tissue Eng Regen Med; 2018 Sep; 12(9):1959-1971. PubMed ID: 30055109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment.
    Reynolds DS; Tevis KM; Blessing WA; Colson YL; Zaman MH; Grinstaff MW
    Sci Rep; 2017 Sep; 7(1):10382. PubMed ID: 28871147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro.
    Liu G; Wang B; Li S; Jin Q; Dai Y
    J Cell Physiol; 2019 Jun; 234(6):9447-9456. PubMed ID: 30478896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds.
    Sims-Mourtada J; Niamat RA; Samuel S; Eskridge C; Kmiec EB
    Int J Nanomedicine; 2014; 9():995-1003. PubMed ID: 24570583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
    Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
    Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
    Yakisich JS; Venkatadri R; Azad N; Iyer AKV
    J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
    Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
    Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).
    Lehuédé C; Li X; Dauvillier S; Vaysse C; Franchet C; Clement E; Esteve D; Longué M; Chaltiel L; Le Gonidec S; Lazar I; Geneste A; Dumontet C; Valet P; Nieto L; Fallone F; Muller C
    Breast Cancer Res; 2019 Jan; 21(1):7. PubMed ID: 30654824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
    Fillmore CM; Kuperwasser C
    Breast Cancer Res; 2008; 10(2):R25. PubMed ID: 18366788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting
    Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
    Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
    Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
    Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
    Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.
    Yang YF; Lee YC; Wang YY; Wang CH; Hou MF; Yuan SF
    Kaohsiung J Med Sci; 2019 Jul; 35(7):408-416. PubMed ID: 31001932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.